Menu
 
Research menu
Jump to menu

Publications:  Ms Monica Canosa

BALKWILL F, Berlato C, Khan MN, Schioppa T, Thompson R, Maniati E, Montfort A, Jangani M et al.(2017). A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. Journal of Clinical Investigation
10.1172/JCI82976
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18188
Kulbe H, Iorio F, Chakravarty P, Milagre CS, Moore R, Thompson RG, Everitt G, Canosa M et al.(2016). Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells. Oncotarget vol. 7, (13) 15648-15661.
10.18632/oncotarget.7255
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22200
Berlato C, Chan KYV, Price AM, Canosa M, Scibetta AG, Hurst HC(2011). Alternative TFAP2A isoforms have distinct activities in breast cancer. Breast Cancer Research vol. 13, (2)
10.1186/bcr2838
Scibetta AG, Wong PP, Chan KYV, Canosa M, Hurst HC(2010). Dual association by TFAP2A during activation of the p21cip/CDKN1A promoter. Cell Cycle vol. 9, (22) 4525-4532.
10.4161/cc.9.22.13746
Williams CMJ, Scibetta AG, Friedrich JK, Canosa M, Berlato C, Moss CH, Hurst HC(2009). AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO J vol. 28, (22) 3591-3601.
10.1038/emboj.2009.290
Williams CMJ, Scibetta AG, Friedrich JK, Canosa M, Berlato C, Moss CH, Hurst HC(2009). AP-2γ promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO Journal vol. 28, (22) 3591-3601.
10.1038/emboj.2009.290
Return to top